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Highlights 
However several transgenic fish lines have been developed in the last few years for studying 
and monitoring estrogenic substances, the transgenic zebrafish line (Tg(vtg1:mCherry)) we 
present here might be a useful tool in endocrine disruptor (EDC) research. The paper 
describes the following: 
 The established transgenic zebrafish line Tg(vtg1:mCherry) expresses the reporter 
(mCherry) under the control of the promoter of the zebrafish vitellogenin1 gene. 
 The incorporated 3357 bp promoter region carries 26 natural ERE sequences and 
is the longest natural promoter region among vitellogenin transgenic lines, 
 The endogenous vitellogenin and the reporter are produced only in the left hepatic 
lobe of 5 dpf zebrafish embryos and show similar spatial expression pattern. 
AC
EP
TE
D M
AN
US
CR
IPT
2 
 
 Tg(vtg1:mCherry) embryos can detect 17-ß-estradiol from a concentration of 100 
ng/L, 17-α-ethynilestradiol from 1 ng/L, zearalenone from 100 ng/L and 
bisphenol-A from 1 mg/L. 
 Tg(vtg1:mCherry) adults appeared to be more sensitive, with detectable transgene 
activity from 5 ng/L 17-ß-estradiol concentration. 
 Tg(vtg1:mCherry) was also suitable for the direct measurement of estrogenicity in 
wastewater samples without sample extraction. 
 
Abstract 
 
Environmental estrogens are a serious concern worldwide due to their ubiquity and adverse 
ecotoxicological and health effects. Chemical structure of these substances is highly diverse, 
therefore estrogenicity cannot be predicted on the basis of molecular structure. Furthermore, 
estimation of estrogenicity of environmental samples based on chemical analytics of suspects 
is difficult given the complex interaction of chemicals and the impact on estrogenicity. The 
full estrogenic impact of an environmental sample can thus only be revealed by a series of 
sensitive in vitro and in vivo ecotoxicological tests. Herein we describe a vitellogenin reporter 
transgenic zebrafish line (Tg(vtg1:mCherry)) that enables the detection of estrogenicity in the 
environmentally relevant, low concentration ranges in embryonic tests that are in accordance 
with 3Rs and relevant animal welfare regulations. 
The transgene construct used for the development of Tg(vtg1:mCherry) carried a long (3.4 
kbp) natural vitellogenin-1 promoter sequence with a high number of ERE sites. 
A test protocol was developed based on our finding that the endogenous vitellogenin and the 
reporter show similar spatial expression pattern and both endogenous and vitellogenin reporter 
is only produced in the left hepatic lobe of 5 dpf zebrafish embryos. 
Seven generations of Tg(vtg1:mCherry) have been established, and the estrogen 
responsiveness was tested with different estrogenic substances and wastewater samples. 
Embryos were exposed from 3 to 5 days post fertilization (dpf). Fluorescence in embryos 
could be detected upon treatment with 17-ß-estradiol from a concentration of 100 ng/L, 17-α-
ethynilestradiol from 1 ng/L, zearalenone from 100 ng/L and bisphenol-A from 1 mg/L. In the 
adult stage transgene activity appeared to be more sensitive to estrogen treatment, with 
detectable transgene activity from 5 ng/L 17-ß-estradiol concentration. The transgenic line 
Tg(vtg1:mCherry) was also suitable for the direct measurement of estrogenicity in wastewater 
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samples without sample extraction. The detection of estrogenic activity using the reporter line 
was confirmed by the bioluminescent yeast estrogen screen. 
 
Keywords: transgenic, vitellogenin, endocrine disrupting chemicals, in vivo, YES 
 
1 Introduction 
 
Environmental estrogens are widely present in the aquatic environment. Due to their 
incomplete breakdown parent compounds and derivatives are detected in the effluents of 
wastewater treatment plants (WWTPs) and surface waters in pg/L to μg/L concentrations 
(Wright-Walters and Volz, 2009). Exposure to environmental estrogens may have serious 
consequences for wildlife populations including feminization of males, altered sex ratios, 
reduced fertility, other gonadal and reproductive abnormalities, immune system and cardiac 
disorders, or development of tumors (Sumpter 2005, Mills and Chichester 2005, Kavlock et al., 
1996) 
Chemical structure of estrogenic substances is highly diverse, therefore estrogenicity cannot 
be predicted solely on the basis of molecular structure. Furthermore, many components in 
environmental samples and their combined effects are unknown and hence deduction of 
estrogenic effects from chemical analysis and detection of know estrogenic compounds could 
be difficult. The full estrogenic impact of an environmental sample can thus only be revealed 
by a complex series of ecotoxicological tests on in vitro and in vivo model systems. Screening 
estrogenic substances in aquatic samples has become a major focus for researchers and 
regulatory authorities in the last two decades, however, due to the high cost and the lack of 
infrastructure these tests are still not part of routine water quality programs in most countries 
(WHO 2012).  
The majority of screening protocols and guidelines proposed by OECD (revised in 2003) is 
based upon the measurement of estrogen receptor (ER) activation in in vitro model systems 
(e.g. Competitive Estrogen Receptor Binding Assay, OECD-TG-455, 457, 493) (OECD 2012) 
or in vivo animal models (such as fish), based on the protein level of estrogen sensitive genes 
(estrogen receptor (ER) and vitellogenin (vtg)) (OECD-TG-229 and 230) (OECD 2012) as 
biomarker. The gene product is usually measured by molecular biological tools and involves 
the sacrifice of the animal model. Most of these tests are using fish from protected life stages. 
As animal protection laws are becoming stricter, there is an increasing demand for alternative 
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test systems by which the number and suffering of experimental animals can be minimized or 
replaced. It is also possible to measure VTG level in the mucus of the epidermis with non-
invasive procedures (Allner et al. 2016), however only in later developmental stages. 
Zebrafish (Danio rerio) can be successfully used for investigating the mode of action of 
estrogenic substances and their reproductive and developmental effects (Segner, 2009). 
Toxicity including organ, tissue and cellular phenotypes can be monitored in the transparent, 
ex utero developing embryo. In addition, embryos of zebrafish up to the free feeding age at 5 
days post fertilization (5 dpf) are considered as non-protected life stages by the EU Directive 
2010/63/EU and relevant national directives and hence represent replacement method for 
testing of (adult) animals (Strähle et al. 2012). 
Several zebrafish lines have been developed recently for the detection of estrogen toxicity. 
Most of these express reporters under the control of estrogen response elements (EREs) and 
are used to visualize the response of estrogen sensitive tissues, estrogen receptor subtype 
specific response and developmental dynamics of estrogen sensitive tissues (Legler et al., 
2000, Gorelick and Halpern 2011, Lee et al., 2012). 
Biosensor fish lines (medaka and zebrafish) and transient systems have also been developed 
with tissue specific promoters of biomarker genes (cyp19a1b, vitellogenin, choriogenin H). 
The most popular biomarker gene in the detection of estrogenicity is vitellogenin. (Wallace 
and Jared, 1968; Lazier and McKay, 1993; Tyler et al., 1999). Vitellogenin transgenic medaka 
(Zeng et al. 2005), zebrafish (ere:zvtg1-gfp) lines (Chen et al, 2010) and transient systems 
(Kim et al., 2009, Lee et al., 2012) have been generated previously, however, sensitivity was 
not tested for the detection of environmentally relevant estrogen concentrations. The 
cyp19a1b-gfp transgenic zebrafish line was shown to detect environmental estrogenicity in 
embryonic stages (Tong et al., 2009, Brion et al., 2012, Petersen et al., 2013, Fetter et al., 
2014). However the fluorescent area represents a relatively small part of the brain and the 
gene is expressed at a basal level in controls too. Recently an estrogen sensitive choriogenin-
H transgenic medaka line, sensitive to the lowest observable estrogen concentration causing 
physiological effects in medaka (15 ng/L 17-α-ethynilestradiol, EE2) has also been developed 
(Spirhanzlova et al., 2016). Besides these, zebrafish cell based in vivo assays are used and are 
capable of detecting well-known estrogenic ligands, but recent study showed that in vivo 
systems show better sensitivity than in vitro assays (Sonavane et al., 2016). 
Routine estrogenicity assays demand the development of new, sensitive biosensor 
models, in which endogenous gene function is in accordance with fluorescent activity. 
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Environmental toxicology also needs models for detecting environmentally relevant estrogen 
concentrations and for studying the effects of environmental estrogens extensively. In this 
report our aim was to develop and characterize a sensitive vitellogenin reporter transgenic 
zebrafish line (Tg(vtg1:mCherry)) and to develop a test protocol for efficient detection of 
estrogenicity in vivo even in environmental samples. 
 
2 Materials and methods 
2.1 Fish maintenance 
All experiments were performed on a laboratory-bred strain (AB) of zebrafish (Danio rerio). 
Prior to treatments fish were maintained in a special zebrafish recirculation system (ZebTEC, 
Tecniplast S.p.a.) under standard laboratory conditions (at 25.5±0.5°C with 14 hour light-10 
hour dark cycle, oxygen level: ≥80% of saturation, pH: 7±0.2 conductivity 525±50 μS/m - all 
these parameters were automatically controlled by the ZebTEC system). 
Adults were fed twice a day with complete fish food (zebrafish basic food, Special Diets 
Services /SDS/) supplemented with freshly hatched live Artemia nauplii twice a week. Larvae 
after the free swimming age were fed three times a day with fish food, supplemented with 
Artemia from 10 dpf (days post fertilization). 
Fish were placed in breeding tanks (Tecniplast S.p.a.) in the afternoon the day before the 
experiment and spawning was triggered by the onset of the light cycle on the next morning. 
One hour after the onset of the light cycle eggs were harvested and normally developing 
embryos were selected under a microscope. 
All embryo handling, injections and treatments of eggs and embryos were carried out in 
“system water” from the recirculation system. 
Experiments were carried out in laboratories possessing required licences for animal 
experimentation (SF/6-8/2014, SF/6-6/2014, XIV-I-001/2303-4/2012)  
 
2.2 Establishment of the vtg1-mCherry transgene construct 
The putative transcription start site was identified upstream the vtg-1 coding sequence by 
PROSCAN 1.7 (Prestridge, 1995). Then the upstream sequence was screened for elements 
needed for the estrogen sensitivity of the construct (EREs - Estrogen Response Elements) by 
DRAGON ERE Finder (Bajic et al., 2003), ALGEN PROMO (Messeguer et al., 2002, Farré 
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et al., 2003) and MATINSPECTOR (GenoMatix) (Quandt et al., 1995, Cartharius et al., 2005) 
softwares and manual sequence analysis. 
Primers were designed for the amplification of a 3357 bp promoter sequence (vtg1 F: 5‘-
TTTATCTTTCCCATGATGACAGCA-3‘, vtg1 R: 5‘-GGCTGGTGGTTTGTGAAGAAC-
3‘), fragments for the gene construct were amplified and recombination sites (attachment 
sites, attB) (attB3: 5‘- GGGGACAAGTTTGTATAATAAAGTAGGCT-3‘, attB5: 5‘-
ACCCAACTTTTGTATACAAAGTGGTCCCC-3‘) were incorporated to the 5’ ends of the 
fragments by PCR (10 x buffer, 0.198 pM forward and reverse primer, 25 nM dNTP, 4 nM 
MgSO4, 1.00 µg DNA, 1 µL enzyme mix Taq DNA Polymerase (recombinant) (Thermo 
Scintific) in 25 μL final volume), reactions were run in an Applied Biosystems 2720 Thermal 
Cycler (94 oC 2 min; 3x 94 oC 1 min, 55 oC 2 min, 70 oC 9 min; 35x 94 oC 2 min, 56 oC 30 
sec, 70 oC 9 min; 70 oC 5 min). The fragment harboring the putative promoter region 
upstream from the vtg-1 transcription start site was amplified from zebrafish genomic DNA, 
while for the amplification of the fluorescent protein encoding sequence, a pCS2 mCherry 
plasmid (modified Addgene plasmid) was used (mCherry F: 5‘-
GCCGCCACCATGGTGAGCAAGGGCGA-3‘, mCherry R: 5‘-
AGATCTCCGCGAATTAAAAAACCTCCCAC-3‘) and attBs sites were incorporated 
(attB1: 5‘-GGGGACAAGTTTGTACAAAAAAGCAGGCT-3‘, attB2: 5‘-
TACCCAGCTTTCTTGTACAAAGTGGTCCCC-3‘) (2x PCR buffer (containing 25mM 
MgCl2), 0.25 nM dNTP, 0.5 pM forward and reverse primer, 1 μg DNA, 0.3 μL Taq 
polymerase; 97 oC 2 min; 35x 94 oC 20 sec, 60 oC 20 sec, 72 oC 3 min; 25x 94 oC 20 sec, 62 
oC 20 sec, 72 oC 3 min). 
PCR products containing different recombination sites (vtg-1 promoter – attB3, attB5, 
mCherryt – attB1, attB2) were cloned into donor plasmids (pDONR221-P1P2 and 
pDONR221-335) by Gateway recombination (BP reaction, Invitrogen, Thermo Fisher 
Sientific). Sequences were then cloned into the final vector (pSP17.2BSSPE-R3-R5-RFA-
Venus Tol2LR) (Gehrig et al., 2009) harboring Tol2 arms by LR cloning (Invitrogen, Thermo 
Fisher Sientific) (Roure, 2007). Plasmids were transformed and propagated in XL10 GOLD 
Escherichia coli competent cells (Agilent) and were pre-screened by colony PCR with M13 
primers (M13F: TGTAAAACGACGGCCAGT, M13R: CAGGAAACAGCTATGAC) as 
recombination sites in donor plasmids are bonded by M13 primer sites (0.16 pM M13 forward 
and reverse  primer, 2 mM MgCl2, 2 mM dNTP, 1 μL Taq polymerase in 25 μL final volume; 
3x 95 oC 2 min, 45 oC 1 min, 72 oC 3 min; 41x 95 oC 30 sec, 45 oC 30 sec, 72 oC 3 min; 72 oC 
5 min). Incorporation of the sequences was checked in purified plasmids by restriction 
digestion. 
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2.3 Establishment of the Tg(vtg1:mCherry) transgenic line 
For efficient transposition, the construct was linearized. Transposase mRNA was synthetized 
from the encoding pCS2 plasmid by mMACHINE Kit (Ambion, Thermo Fisher Sientific). 
The construct (25 ng) was co-injected with transposase mRNA (25 ng) into the yolk of 
embryos by microinjection. 
Transient expression of the reporter gene was examined in 5 dpf embryos following 100 ng/L 
17-ß-estradiol (E2) treatment under a fluorescent microscope (Leica M205 FA, Leica DFC 
425C camera, LAS V3.8 softer) using RFP filter. 
Untreated embryos injected with the reporter gene construct were raised until fertility and 
crossed to wild-type zebrafish. The gene construct transmitting (so-called P0) founders were 
selected by fluorescent microscopy following 100 ng/L EE2 treatment (5 days of exposure, 
30-70 embryos/treatment) and mCherry specific PCR of estrogen treated offspring (mCherry 
check F: 5’-GGGCGAGATCAAGCAGAGG-3’, mCherry check R: 5'-
CACAACGAGGACTACACCATCG-3', 10x TaqMan buffer, 0.4752 pM forward and reverse 
primer, 2.5 mM dNTP, 2 mM MgCl2, 1 μL Taq polymerase; 95 oC 1 min; 35x 95 oC 15 sec, 
56 oC 20 sec, 72 oC 1 min; 72 oC 3 min). 
Offspring of founders found positive by the PCR were raised and used to establish the F1 
generation of the Tg(vtg1:mCherry) line. F2 was generated by mating 6 selected F1 
individuals (3 males and 3 females) with wild-type fish. F2 were then crossed again with 
wild-type individuals. F4 generation was established by intra- and intergenerational crossing 
of F2 and F3 “transgene carriers”. The above mentioned microscopic examination was carried 
out in every generation while prior to the establishment of F4, PCR-based selection was also 
carried out to generate homozygous individuals. Homozygosity was confirmed by crossing 
these selected fish to wildtype, non-transgenic fish (test cross). Further generations (F5, F6 
and F7) were generated by mating selected individuals of the previous generation inter se. 
2.4 Evaluation of the fluorescent response in heterozygous and homozygous embryos 
Homozygous individuals were crossed inter se and to wild-type fish to generate homozygous 
and heterozygous embryos. Larvae (from 3 dpf) were exposed to 100 g/L E2 in 5 replicates 
containing 20 embryos / replicate, in static conditions. Embryos were examined under the 
microscope at 5 dpf from left lateral view. Number of fluorescent embryos and fluorescent 
signal were determined for both groups and results were compared to each other by the Mann-
Whitney test. 
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2.5 Characterization of mCherry transcription 
For the characterization of mCherry expression 500 F3 embryos were exposed to 200 ng/L 
17-α-ethinyl-estradiol (EE2) from 0 dpf, and studied daily under a fluorescent microscope at 
different magnifications. Exposure solution was changed daily. 
2.6 Testing mCherry inducibility by estrogenic substances 
In F3 and F4 generations, fluorescent protein induction was tested with several concentrations 
of other estrogenic compounds. As it was found that the fluorescent signal was induced from 
2-3 dpf and was strong from 3 dpf the exposure period was changed from 5 days (0 dpf-5 dpf) 
to 2 days (from 3 to 5dpf). The exposure was carried out in three replicates with 20 
embryos/concentrations and solution was changed daily. 
F4 embryos were exposed to E2 (200; 100; 50; 25; 12.5; 6.25; 0.1 μg/L), EE2 (200; 100; 50; 
25; 12.5; 6.25; 3.125 ng/L), zearalenone (ZEA) (500; 250; 100; 50; 10; 5; 1; 0.1 μg/L), 
bisphenol-A (BPA) (20; 10; 8; 6; 5; 2.5; 1; 0.1; 0.01 mg/L), nonylphenol (NP) (300, 150, 75 
μg/L) and atrazine (ATR) (10000; 1000; 100; 50; 25; 25; 12.5; 6.25 μg/L). All agents were 
purchased from Sigma-Aldrich. Treatments were carried out in petri-dishes, at 27.5 °C. The 
effects of solvents used for the stock solutions (ethanol (Reanal) for E2, EE2, ZEA and BPA 
and DMSO (Sigma-Aldrich) for ATR) were tested at the solvent concentration of the highest 
test concentration. 
 
2.7 Imaging and analysis 
Prior to microscopic analysis, embryos were anaesthetized in 0.02% MS-222 (Tricaine-
methane-sulphonate, Sigma-Aldrich) solution, then larvae were oriented (to the left side) in 
0.5% methyl-cellulose. Bright field and fluorescent images were captured from all embryos in 
30x magnification (exposure time: 1s, Leica M205 FA, Leica DFC 425C camera, LAS V3.8 
software). 
Signal in the red range of the RGB (Red, Green, Blue) color range was evaluated by ImageJ 
software (Schneider et al., 2012). An elliptical area of the same size was selected on all 
images and moved to the area of the liver, then the signal strength and the size of the affected 
area was determined. From the two values an integrated value (Integrated density) was 
generated and the level of induction was calculated on the basis of comparison with controls. 
The estrogenicity (so-called relative estrogenic potency) of tested chemicals was determined 
by comparing the EC50 integrated densityof compounds to the EC50 integrated densityof E2. 
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2.8 Testing the mCherry induction in males 
Adult (3-month-old) males from the F1 generation were exposed to 5, 10, 50 and 100 ng/L E2 
for 4 days. Treatments were carried out in two replicates in 3 liter tanks containing 15 
individuals each, in semi-static conditions (water exchange was carried out daily). Induction 
of the fluorescent signal was observed under a fluorescent microscope in vivo (through the 
body). Individuals were anaesthetized in 0.02% MS-222 (Sigma-Aldrich) prior to the 
examination. 
 
2.9 Vitellogenin „whole mount” in situ hybridization 
Expression of the endogenous vtg gene was examined in wild-type and transgenic embryos. 
Wild type embryos (50) and transgenic embryos (20) were exposed to 200 ng/L EE2 from 0 
to 5 dpf. Exposure solution was changed daily. 
In situ hybridization was carried out with a 545 bp probe designed for the vtg mRNA 
according to the protocol developed for zebrafish embryos by Thisse and Thisse (2008). Total 
RNA of estrogen treated embryos was reverse transcribed (Omniscript RT kit, Qiagen) and 
the probe sequence was amplified by PCR (vtg1 pr 6F: 5’-GTACTTGGCACACCATAGCG-
3’, vtg1 pr 6R: 5'-TCAAGGACCTCTGAGATGGC-3') (10x Finnzym buffer (containing 
MgCl2, 0.198 pM forward and reverse primer, 0.5 mM dNTP, 0.12 μL Taq polymerase; 95 oC 
1 min; 40x 95 oC 15 sec, 56 oC 40 sec, 72 oC 4 min; 72 oC 3 min). Purified PCR product was 
ligated to pCRII plasmid (Dual Promoter TA cloning Kit, Invitrogen, Thermo Fisher 
Sientific), plasmids were propagated in TOP10 E. coli competent cells (Thermo Fisher 
Sientific) then colonies were selected by colony PCR. Carrier plasmids were linearized and 
DIG-labelled antisense RNA probe was generated by in vitro transcription (DIG RNA 
Labeling Kit SP6/T7, Roche). 
 
2.10 Testing wastewater samples 
During the summer season, five effluent samples were collected from the activated sludge 
containing phase in a wastewater treatment plant in Gödöllő (Hungary), that uses UTB’s 
Cyclator technology to treat local municipal wastewater (roughly 6500 PE). 
 
2.10.1 Zebrafish wastewater exposure 
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Zebrafish embryos (F7) were exposed from 3 to 5 dpf directly to wastewater samples (100%) 
and dilutions (25; 37.5 and 50%) in three replicates (20 embryo/replicate), in static conditions. 
100 ng/L E2 was used as positive control and system water as negative control. Treatments 
were carried out in petri-dishes, at 27.5 °C. Microscopy and evaluation was carried out as 
above. 
 
2.10.2 Result verification by the yeast estrogen screening assay (BLYES) 
For the BLYES test, wastewater samples were filtered through a membrane filter (0.45 µm). 
Samples were diluted with system water to 25; 37.5 and 50% sample final concentration and applied 
directly in the assays. 
Final growth 1X yeast minimal medium (1X YMM leu-, ura-) was applied for growing 
Saccharomyces cerevisiae BLYES strain (Routledge and Sumpter, 1996; Sanseverino et al., 
2005) at 30 oC and 170 rpm. The overnight culture of BLYES was centrifuged (4000 rpm, 
4°C, 20 min) and the optical density was set with final growth 2X YMM (leu-, ura-) to OD600 
value of 2.0. The measurement was carried out in 3 parallels using a 96-well microplate 
(Greiner Bio-one Gmbh, Germany). The serial dilution of 17-ß-estradiol served as positive 
control. The stock solution was made in system water. Negative controls (final growth 2X 
YMM and yeast cells) and solvent controls (final growth 2X YMM, yeast cells and system 
water) were also applied. 
100 µl diluted wastewater samples were transferred to the wells of the microplate and 100 µl 
of the yeast cells were also added. Bioluminescence was measured after 5 hours of incubation 
at 30oC by VictorX Multilabel Plate Reader (Perkin Elmer Inc.). 
Data analysis involved the determination of the EC50 value of the positive control and the 
bioluminescence intensification values (Froehner et al., 2002) of the positive control and the 
wastewater sample. 
𝐵𝑖𝑜𝑙𝑢𝑚𝑖𝑛𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 (%) = −[
(𝐶 − 𝑆)
𝐶
∗ 100] 
where 
C is the mean bioluminescence (cps) value of the negative control 
S is the mean bioluminescence (cps) value of the tested samples. 
Samples were considered to be estrogenic if the bioluminescence intensification value was ≥ 
20%. 
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2.11 Dose-response diagrams, statistical analysis 
For the evaluation of fluorescence by image analysis and integrated density quantification, 
outliers were removed by the ROUT method (Motulsky and Brown 2006) and dose-response 
analysis was carried out following the log transformation and normalization of results. 
Sigmoidal dose-response diagrams were generated by non-linear regression and plotted with 
GraphPad Prism 4.0 (graphpad.com). EC10 and EC90 values were calculated according to the 
recommendations of GraphPad (ECF= (F/100-F)
1/H x EC50) (F=effective concentration %, 
H=slope of the dose-response curve). 
3 Results and discussion 
3.1 Establishment of an estrogen sensitive biomarker zebrafish line 
To develop a biomarker transgenic line, a vitellogenin (vtg-1) promoter region - 
anticipated to represent a sensitive promoter for the estrogen-dependent expression of the 
reporter (mCherry) - was selected on the basis of bioinformatical analysis. First, the putative 
transcription start site (TSS) was identified, then the region was examined for potential ERE 
sequences upstream to the TSS. On the 3357 bp promoter region, which is located on 
zebrafish chromosome 22 (positive strand, 24710551-24713908, GRCz10/danRer10, Sept. 
2014, UCSC Genome Browser, previously Zv9/danRer7, July 2010, UCSC Genome 
Browser), 10 potential ERE sites were found with ALGEN PROMO, 5 half ERE sites with 
MATINSPECTOR and one full, previously undescribed sequence (5‘-
CAGGGCAACCTAACCCA -3‘) with DRAGON ERE software. Additionally, based on 
sequences described in the literature (Klinge et al., 1997) 10 half ERE sites were found. The 
fragment carries 26 ERE sequences, while on the 1700 bp promoter sequence of a previously 
developed vtg transgenic zebrafish line (ere:zvtg1-gfp) (Chen et al., 2010), only 12 ERE 
sequences can be identified. These regions overlap, so the vtg1-mCherry construct harbors 17, 
while the ere-zvtg1:gfp line carries 8 ERE regions altogether (Figure 1). The full, previously 
undescribed ERE sequence identified on the vtg1 promoter sequence in the vtg1-mCherry 
transgene construct is part of the ere:zvtg1-gfp construct. The Tg(vtg1:mCherry) transgene 
construct was anticipated to mimic the expression of the native vtg gene, as it carries the 
longest natural promoter region used among vtg transgenic laboratory model fish lines and 
lacks artificial ERE sequences. 
To test the expression of the construct (vtg1:mCherry), transient expression was analyzed in 
embryos following five days of exposure to 17-ß-estradiol under a fluorescent microscope. 
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The fluorescent signal appeared in 20% of embryos injected with the transgene construct. In 
addition to the fluorescence in the liver (Figure 2), the majority of embryos expressed strong 
transient fluorescent signal in the yolk, while in some embryos (<1%) weak expression was 
observed in the eye and kidney. Thus the functionality of the vtg1::mCherry construct was 
proven. Founders of the construct were identified and used for generation of a stable 
transgenic line. 
In F1 embryos, fluorescent protein expression disappeared from the kidney and eye region, 
while it was still detected in the yolk in response to estrogen, suggesting that the signal is a 
result of transgene activity. Estrogen inducible fluorescent signal still appeared in the yolk of 
embryos in all subsequent generations, with a percentage of 5-100%. From F3, 3 distinct lines 
were generated from the offspring of 3 founder pairs. Although fluorescence in the yolk was 
relatively strong in case of one line, its offspring proved to be highly sensitive to estrogens. The 
other two lines showed no unspecific fluorescent activity. Fish were maintained as heterozygotes 
for the transgene until F3. In F3 and F4, homozygous individuals were generated by crossing 
siblings and verified by test crosses with non-transgenic wild type fish. From F4 the line has been 
maintained in homozygous form. 
3.2 Comparison of the fluorescent signal in homozygous and heterozygous embryos of the 
(Tg(vtg1:mCherry)) line 
It was supposed that fluorescent signal intensity in homozygous and heterozygous 
embryos are different, as homozygous individuals carry two transgene alleles. So 
homozygous and heterozygous larvae were compared on the basis of response to 100 g/L 
E2. Significant difference was found in the number of fluorescent fish (P=0.0079), and also in 
integrated density (P=0,0110) (Figure 3), therefore from F3, only homozygous embryos were 
used in the experiments. 
3.3 Pretesting the concentration dependency of the fluorescent signal in (Tg(vtg1:mCherry) 
F3 embryos 
Concentration dependency of the fluorescent signal was first examined in F3 embryos 
following exposures to estrogenic substances from 3 to 5 dpf. Due to inhomogeneity, results 
showed a large variation. Exposures were carried out with E2, EE2 and ZEA, but significant 
signal intensity differences were only observed in case of EE2 (results not shown). There was no 
fluorescent signal in the solvent control in either case. All of the three lines proved to be suitable 
for the detection of estrogenicity, however subsequent experiments were performed on the line 
showing the highest level of induction. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
13 
 
3.4 Adult male (Tg(vtg1:mCherry)) exposure to 17-β-estradiol 
Vtg is normally expressed in a high level in mature females, while in males the level is 
very low (Wallace and Jared, 1968; Lazier and McKay, 1993; Tyler et al., 1996, 1999a, b; 
Baumann et al., 2013). As in embryos, vitellogenin production in males can be triggered by 
exposure to estrogens too, and the effect exhibits concentration-dependency. In the liver of 
untreated females mCherry fluorescence can already be observed through the pigmented skin, 
while in males the fluorescent signal is undetectable (Figure 4) even after autopsy. 
Inducibility of the transgene was demonstrated by E2 treatment of mature males. The 
reporter gene appeared to show a concentration-dependent response. Tg(vtg1:mCherry) males 
could detect E2 from 5 ng/L (Figure 5), that is lower than the E2 concentration detectable by  
the ere:zvtg1-gfp line (Chen et al., 2010). Moreover, fluorescence appeared at an earlier time 
point (at the second day of exposure) at higher concentrations (100 ng/L). Further 
concentrations were not tested on adults and hence, no EC50 concentrations were determined 
for adult fish. By the end of the exposure period, fluorescent activity was detectable in the 
liver of all treated individuals. Tg(vtg1:mCherry) is likely to detect lower concentrations too 
in longer exposure periods, as the ere:zvtg1-gfp line (Chen et al., 2010) gave a response to the 
lowest concentration only after 7 days of exposure. 
It seems that mature vtg1:mCherry males are probably more sensitive to E2 than 
embryos. On the basis of literature, estrogen sensitivity of zebrafish is gradually increasing 
with the development of gonads, and the pattern of receptor paralogs and their expression also 
changes. In the liver of embryos, only the ß2 receptor is present. The liver of adult males 
express all three estrogen receptors (α, ß1, ß2) (Bardet et al., 2002) which could impact on the 
sensitivity and compound specificity if compared to embryos. 
3.5 Examination of the expression of the fluorescent signal at different developmental 
stages 
To establish an appropriate test protocol for the Tg(vtg1:mCherry) line, mCherry 
transcription was characterized in F3 homozygous embryos exposed to 17-α-ethinyl-estradiol 
(EE2). 
Initially embryo exposures were carried out from 0 to 5 dpf. However liver 
development in zebrafish starts at 6 hpf, and the functional organ is formed at 50 hpf (Tao and 
Peng, 2009), results proved that vitellogenin production begins in later stages. The fluorescent 
signal was induced from 2-3 dpf and was strong from 3 dpf. The size of the fluorescent area 
increased gradually along with liver development and reached the maximum at 5 dpf in the 
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experimental period (Figure 6). This is in accordance with previous findings that the liver of 
the zebrafish embryo is able to produce vtg from 2-3 dpf (Chen et al., 2010). Therefore, the 
exposure period was changed from 5 days (0 dpf-5 dpf) to 2 days (from 3 to 5dpf) in further 
experiments. 
 
3.6 Characterisation of endogenous vitellogenin expression in wild-type and transgenic 
embryos by Vtg in situ hybridisation 
Regardless of the test compound or concentration, the reporter activity in the liver of 
embryos varied in all generations and lines exposed. The size of the expression area and 
strength of the fluorescent signal showed no correlation (data not shown). Therefore 
endogenous vitellogenin expression was characterized in wild-type and transgenic embryos to 
show if variability is also found for the native vtg expression. 
Vitellogenin RNA in situ hybridization showed that in case of both wild-type and 
transgenic embryos the gene was not induced in all individuals, and embryos expressing vtg 
exhibit variability in the area of expression (Figure 7). 
In situ hybridization images of transgenic embryos were compared to fluorescent 
images captured before fixation. Results clearly showed that the differences in endogenous 
vtg production overlap with the differences detected in mCherry expression (Figure 8). 
Interestingly, although 5 dpf zebrafish embryos have developed both liver lobes (Tao 
and Peng, 2009; Chu and Sadler, 2009), the production of vtg at this stage was consistently 
observed only in the left lobe for both endogenous vtg and transgene, further confirming that 
the transgene is regulated similar to the endogenous vtg gene (Figure 9). 
The number of fluorescent embryos was found to be substance and dose dependent in 
the ere:zvtg1-gfp (Chen et al., 2010) and the 3pERE-TATA-Gal4ff (Lee et al., 2012) transgenic 
zebrafish lines too. This experiment showed that variability in the mCherry signal is 
associated with variability of the native vtg expression, which accounts for high biological 
variability. On the basis of these a minimum of 20 embryos per concentration in replicated 
experiments should be exposed to demonstrate concentration-dependent expression of the 
transgene. The source of variability is not known but could e.g. be associated with individual 
differences of concentrations at the target site or genetic factors and may be reduced by 
establishing inbred strains. 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
15 
 
3.7 Sensitivity of the Tg(vtg1:mCherry) transgenic line to estrogenic substances 
To test the sensitivity of Tg(vtg1:mCherry), dose-response was studied with E2, EE2, 
ZEA, BPA, NP and ATR. Concentration dependent fluorescent response was detected in case 
of E2, EE2, ZEA and BPA (Figure 10). The lowest effective concentration (LOEC) of 
mCherry expression was 0.1 mg/L for E2, 6.25 ng/L for EE2, 0.1 µg/L for ZEA and 1.25 
mg/L for BPA. LC values and estrogen equivalents are shown in Figure 11. In case of NP the 
fluorescent protein was expressed only in a few embryos, in a very small area of the liver. 
ATR in this developmental stage had no effect on vtg levels and there was no fluorescent 
signal in the solvent control in either case. 
It is not easy to compare the sensitivity of the Tg(vtg1:mCherry) line to other estrogen 
detecting transgenic lines, as the exposure protocols and evaluation processes are different. 
Based on published data, the detectable estrogenic substance concentrations by 
Tg(vtg1:mCherry) embryos are similar to that of zvtg1-gfp (Chen et al., 2010), except for 
ZEA, however in the latter case exposure was carried out from 7 to 20 dpf, when the number 
of estrogen receptors is higher than at 5 dpf. EC50 levels calculated from dose-response curves 
of the aromatase biosensor line (Brion et al., 2012) are lower than the EC50 values of the new 
transgenic line. The difference in EC values is probably due to the different sensitivity of the 
genes and the different number and type of estrogen receptors expressed in the two organs. 
NP triggered response only in a few embryos of the Tg(vtg1:mCherry) line, and the 
expression was restricted to a very small area of the liver. The zvtg1-gfp (Chen et al., 2010) 
line did not respond to NP, while the aromatase transgenic line (Brion et al., 2012) could 
detect the estrogenicity of a mixture of 4-nonyl-phenols with an EC50 of 406 nM. 
On the basis of EC50 values of fluorescent protein induction, BPA proved to be approx. 
3000x weaker, ZEA was nearly equivalent, while EE2 was an approx. 273x stronger 
estrogenic substance compared to natural estrogen (Figure 11). On the basis of literature EE2 
seems to be about 16.48x more estrogenic than E2 (Rose et al., 2002). The most striking result 
was the almost similar estrogenicity of E2 and ZEA. According to data described so far the 
estrogenic effect of ZEA compared to E2 varies in a very large range, and is 5.4-1439x 
weaker than E2 (Schwartz et al., 2010; Arukwe et al., 1999; Le Guevel and Packdel, 2001; 
Olsen et al., 2005; Tollefsen et al., 2003). Variance might be due to different model systems 
and methods, however none have shown similar estrogenicity of these agents. Presumably 
embryos may have weaker biotransformation of the parent compound, or ZEA is diffusing 
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easily in the embryo, keeping internal concentrations of the parent compound higher than in 
an adult animal. 
 
3.8 Testing estrogenicity of wastewater samples in Tg(vtg1:mCherry) embryos 
 
To test if embryos are suitable for screening environmental estrogenicity, F7 
Tg(vtg1:mCherry) embryos were exposed to undiluted and diluted effluent samples that were 
taken from the activated sludge containing phase. Embryos showed no fluorescent signal in 
four (WW1, WW2, WW3 and WW5) wastewater samples, while in the case of WW4, 
fluorescence was detected in the liver even at the lowest dilution (25%) (Figure 12A). The 
intensity of the signal increased gradually with concentration. The raw, undiluted sample was 
probably too concentrated for the fish and caused significant lethality and weaker 
fluorescence. These results were confirmed by BLYES test. According to the concentration-
response curve of the positive control 17-ß-estradiol (data not shown), the EC50 value was 
1.79 nM. This concentration caused 632% bioluminescence intensification in the BLYES test. 
Similarly as observed for embryos the other four wastewater effluents (WW1, WW2, 
WW3 and WW5) did not induce bioluminescence (Figure 12B). This indicates that the 
Tg(vtg1:mCherry) line is suitable for testing wastewater and environmental samples. 
 
4  
5 Conclusions 
In the present study we have established and characterized a transgenic zebrafish line 
(Tg(vtg1:mCherry)) that - in the presence of estrogenic substances - produces red fluorescent 
protein in the liver. The sensitivity was tested with different estrogenic substances in the fourth 
generation. According to liver development and the first appearance of the fluorescent signal 
during development, the exposure period was shortened from 5 to 2 days (3 to 5 dpf). 
Fluorescence in embryos could be detected upon treatment with 17-ß-estradiol from a 
concentration of 100 ng/L, 17-α-ethynilestradiol from 1 ng/L, zearalenone from 100 ng/L and 
bisphenol-A from 1 mg/L respectively. Transgene activity appeared to be more sensitive to 
treatment (E2) in the adult stage, with detectable transgene activity from 5 ng/L concentration. 
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The Tg(vtg1:mCherry) transgenic line could detect estrogenicity in wastewater samples  
following direct exposure with the same sensitivity as the commonly used yeast estrogen test, 
BLYES. 
Results suggest that sensitivity of the Tg(vtg1:mCherry) line is in the range of 
environmentally relevant concentrations (detected in waters or effluents), and could detect 
estrogenicity in wastewater. On the basis of these, Tg(vtg1:mCherry) with the developed test 
protocol could be a sufficient tool in assessing environmental estrogenicity in the future. In 
addition to environmental toxicology tests this transgenic line may help in determining the 
onset of estrogen synthesis during sexual development and in investigating the molecular 
background of estrogenic effects and vitellogenin induction by morpholino injection or gene 
knockout. Females could also be subjects of examining androgens where the effect could be 
evaluated on the basis of the decrease in the strength of the fluorescent signal. Moreover, 
adverse effects of toxic substances on the liver may also be studied in vivo. 
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Figure legends: 
 
 
Figure 1. Half and full estrogen responsive elements on the 1700 bp fragment of the 
vitellogenin-1 promoter of the ere:zvtg1-gfp line (Chen et al., 2010) (A) and on the 3357 bp 
vitellogenin-1 promoter fragment of the Tg(vtg1:mCherry) line (B). Sites were identified on 
the basis of literature and by specific softwares (rectangles (sequences described in literature): 
TGACC (203-207, 1245-1249), CAGCTG (519-524, 1692-1697, 2601-2606), GGTCA 
(1512-1516, 2448-2452, 3290-3294), CAGTCA (2553-2558), TGACT (2563-2567), triangles 
(ALGEN PROMO): TGACCTTAA (202-210), TGACCTTAAA (202-211), TTGACCAG 
(201-208), TTGACCAG (1243-1251), TGACCAGAT (1244-1252), GCACGGTCA (1507- 
1515), ACGGTCAA (1509-1516), CAAGGGTCA (2443- 2451), AGGGTCAG (2445-2452), 
ACTTGGTCA (3285-3293), TTGGTCAG (3287-3294), circles (MATINSPECTOR):, 
TCCAGAGGTTAGGTTAACCTGGC (165-187), ATGACAGGCCAGGTTAACCTAAC 
(172-194), GGGGCAGGGCAACCTAACCCAAA (2163-2185), 
ATTAAGGGGCAGGGCAACCTAAC (2168-2190), TATACAGGTTAAAGTGACATTTA 
(3273-3295), star (DRAGON ERE FINDER): CAGGGCAACCTAACCCA (1240-1257). The 
only full, newly identified ERE sequence is highlighted with a circle. The putative 
transcription start site (TSS) is indicated by an arrow. 
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Figure 2. Red fluorescent signal in the liver of injected 5 dpf embryos, following E2 induction 
(right). In non-treated controls (left) no signal was detected. Liver is indicated by arrows. (BF: 
bright field, mCherry: red fluorescent filter view, single plain images)  
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Figure 3. Fluorescence in homozygous and heterozygous embryos were compared under the 
microscope following exposure to 100 g/L E2 from 3 to 5 dpf. Significant difference was 
detected both in the number of fluorescent fish (A) (P=0.0079, Mann-Whitney test) and the 
integrated density value (B) (P=0.0110, Mann-Whitney test) based on the intensity and spatial 
distribution of the fluorescent signal. AC
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Figure 4. Fluorescence in untreated adult vtg1:mCherry transgenic males (9 months old) is 
undetectable while strong fluorescence of the liver in untreated females is visible even 
through the pigmented skin (BF: bright field, mCherry: red fluorescent filter view, single 
plain images). 
 
Figure 5. Fluorescent signal in a 9-month-old, untreated control male and 9-month-old 17-ß-
estradiol treated males (E2: 17-ß-estradiol, BF: bright field, mCherry: red fluorescent filter 
view, single plain images, fluorescent signal is shown by arrows) 
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Figure 6. Fluorescent signal in developing transgenic embryos (vtg1-mCherry) exposed to 
EE2 (200 ng/L). Expression was detected in the liver (indicated by arrows) 3 dpf. (BF: bright 
field, mCherry: red fluorescent filter view, single plain images) Scale bar: 1mm. 
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Figure 7. Whole mount in situ hybridization of 5 dpf, 17--ethynil-estradiol treated (200 ng/L 
EE2), wild-type embryos shown individual differences in vtg-1 expression (liver is indicated 
by arrows on single plain images) 
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Figure 8. Similar biological variability of vtg and transgene response was clearly shown by 
comparing in situ hybridization images of 5 dpf transgenic embryos (vtg1:mCherry) to 
fluorescent images captured before fixation. Endogenous vtg production functioned similarly 
to the fluorescent protein, regarding spatial distribution and strength of the signal. Embryos 
were treated with 200 ng/L EE2. (vtg-1 WISH: vitellogenin-1 whole mount in situ 
hybridization, mCherry: red fluorescent filter view, single plain images, liver indicated by 
arrows)). 
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Figure 9. Expression of vtg-1 was restricted to the left liver lobe (in 5 dpf wild-type larvae 
following 200 ng/L EE2 treatment) (dorsal (A) and left lateral (B) view, liver is indicated by 
arrows on single plain images). 
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Figure 10. Dose-response diagrams for exposures to 17-ß-estradiol (E2), 17-α-ethynil-
estradiol (EE2), bisphenol-A (BPA) and zearalenone (ZEA) in 5 dpf vtg1-mCherry larvae. 
Results are expressed as integrated density generated from signal strength and the size of the 
affected area (±SEM, n=.60) (A). Fluorescent images (mCherry) of the liver of E2 exposed 
larvae. Signal intensity increased gradually with concentration. (B) 100% refers to the 
observed maximum for each compound. 
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Figure 11. EC50, EC10 and EC90 values and estrogenic potencies relative to 17-ß-estradiol for 
estrogenic substances based on the results of the vtg1-mCherry transgenic line (17-ß-estradiol 
(E2), 17-α-ethynil-estradiol (EE2), zearalenone (ZEA) and bisphenol-A (BPA)) 
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Fig. 12. Dose-response curves for wastewater (sample WW4) exposure in 5 dpf vtg1-mCherry 
larvae (A) and the BLYES test (B). Results are expressed as integrated density generated from 
signal strength and the size of the affected area (±SEM, n=.60) in case of zebrafish. On figure 
B, Y-axis indicates fold change bioluminescent intensification compared to the 
bioluminescence of the negative control. Undiluted samples could not be tested in the BLYES 
system. 
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